Apogee Therapeutics (APGE) Share-based Compensation (2023 - 2026)
Apogee Therapeutics' Share-based Compensation was $16.66 million in Q2 2026, up 46.9% from $11.34 million a year earlier but down 2.9% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Share-based Compensation (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Apogee Therapeutics' Share-based Compensation was $57.63 million through Jun 30, 2026, up 60.4% year-over-year; for FY2025, it came in at $46.28 million, up 98.3% from FY2024.
- Share-based Compensation has now increased for three consecutive years, with a three-year compound annual growth rate of 178.5% (FY2022 to FY2025).
- In earlier years, Share-based Compensation was $23.33 million in FY2024 (+282.3%), $6.1 million in FY2023 (+184.9%) and $2.14 million in FY2022.
- Quarterly Share-based Compensation has moved between $1.11 million (Q2 2023) and $17.16 million (Q1 2026) over five years.
- Compared with a year earlier, Share-based Compensation has increased for ten straight quarters, with growth averaging 132.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Share-based Compensation ran from 46.9% in Q2 2026 to 411.9% in Q2 2024.
- Per Business Quant data, APGE's Share-based Compensation in the three quarters before Q2 2026 was $17.16 million (Q1 2026), $11.93 million (Q4 2025) and $11.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 16.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.66 Mn |
| Mar 31, 2026 | 17.16 Mn |
| Dec 31, 2025 | 11.93 Mn |
| Sep 30, 2025 | 11.88 Mn |
| Jun 30, 2025 | 11.34 Mn |
| Mar 31, 2025 | 11.13 Mn |
| Dec 31, 2024 | 7.61 Mn |
| Sep 30, 2024 | 5.84 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.27 Mn |
API Access
Apogee Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();